CA
NZ
UK
AU
IND
US
The rally at PacBio (NASDAQ:PACB) came from partner news built on its HiFi long-read sequencing, not from a company earnings release. EpiSign launched METRIC 5-base software for DNA methylation analysis on PacBio HiFi data on September 30, 2026, and on October 5 EpiSign and …
Silence Therapeutics, an RNA interference company, and Merck KGaA announced the transaction on October 19, 2026 in separate statements. Merck KGaA will pay USD 20 in cash for each ADS, an all-cash deal valued at about USD 1.3 billion. On the day Silence Therapeutics …
Katapult Holdings (NASDAQ:KPLT) issued no news release in September or October 2026 that explains the move, and the latest company items found are the August 11 completion of the merger and the August 4 second quarter results. Reported prices rose from about USD 4.50 …
Prime Medicine (NASDAQ:PRME) develops prime editing, a gene editing approach designed to correct mutations in the body without cutting both DNA strands. On October 5, 2026 it said the first patient had been dosed with PM577a, an in vivo prime editor for Wilson disease …
No company announcement, filing or analyst action dated within the past month explains the 76.71% gain in Akso Health Group (NASDAQ:AHG). The stock fell 5.6% on October 21 and rose 6.8% on October 22 in published data with no stated cause, and similar swings …
Rapid7 (NASDAQ:RPD) released no acquisition, activist or guidance news in its own items from September 3 to October 21, 2026. Those items are conference appearances, inducement grants of 290,626 and 455,621 restricted stock units, the October 2 launch of Rapid7 Intelligence, and a threat …
Myriad Genetics (NASDAQ:MYGN) disclosed in an 8-K dated October 19, 2026 a definitive agreement to sell its Prenatal Health testing business, including the Prequel, Foresight, SneakPeek and FirstGene tests, to Labcorp for USD 210 million in cash plus inventory at closing. Closing is expected …
Evernorth (NASDAQ:XRPN) is an actively managed XRP treasury company. It completed a business combination with Armada Acquisition Corp. II, a special purpose acquisition company sponsored by Arrington XRP Capital Fund, and its shares began trading on Nasdaq under the symbol XRPN in October 2026, …
On October 8, 2026 Viatris announced a plan to acquire Pacira BioSciences (NASDAQ:PCRX), a specialty pharmaceutical company focused on non-opioid pain management, for USD 36.50 per share in cash. The report reviewed puts the equity value at about USD 1.65 billion and describes a …
Black Rock Coffee Bar (NASDAQ:BRCB) has announced no deal, guidance change or financing in the past month, and the gain follows a long decline from a 52-week high of USD 26.48. The shares are down 54.66% year to date and 61.11% over one year, …
Please wait processing your request...